ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

    Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation

    Guides
    | 2010 | Agilent Technologies
    GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS
    Instrumentation
    GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    End-To-End Spectroscopy-Based Workflow Solutions for Oligonucleotide Analysis

    Brochures and specifications
    | 2023 | Agilent Technologies
    GC, GC/MSD, HeadSpace, GC/SQ, Software, HPLC, RAMAN Spectroscopy, UV–VIS spectrophotometry, ICP/MS, FTIR Spectroscopy
    Instrumentation
    GC, GC/MSD, HeadSpace, GC/SQ, Software, HPLC, RAMAN Spectroscopy, UV–VIS spectrophotometry, ICP/MS, FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Sanofi-aventis - A high throughput assay for oxaliplatin in clinical samples

    Others
    | 2007 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution

    Technical notes
    | 2021 | Agilent Technologies
    Software, HPLC, ICP/MS, Speciation analysis
    Instrumentation
    Software, HPLC, ICP/MS, Speciation analysis
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

    Applications
    | 2016 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Enterprise Content Manager (ECM)

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Measuring Elemental Impurities in Pharmaceutical Materials

    Brochures and specifications
    | 2022 | Agilent Technologies
    Consumables, ICP/MS, ICP/OES
    Instrumentation
    Consumables, ICP/MS, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Agilent ICP-MS Journal (February 2010 – Issue 41)

    Others
    | 2010 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma, Clinical Research

    Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

    Applications
    | 2016 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Monitoring of Metal Elements in CHO Cell Culture Supernatant Using ICPMS-203

    Applications
    | 2022 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma
     

    Related content


    Advances in Chromatography and Electrophoresis & Chiranal 2024 (Programme)

    Mo, 13.5.2024
    Advances in Chromatography and Electrophoresis & Chiranal

    Mother’s protein intake during pregnancy can affect newborn’s facial development

    Su, 12.5.2024
    CEITEC

    Material genetics will be pursued by the AMULET project, which succeeded in the Excellent Research Call

    Th, 9.5.2024
    Ústav organické chemie a biochemie AV ČR
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike